465 filings
Page 12 of 24
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
21 Feb 19
Current report (foreign)
9:15am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
14 Feb 19
At Market Issuance Sales Agreement
8:13am
424B5
ACST
Acasti Pharma Inc - Ordinary Shares
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
14 Feb 19
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019
8:05am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
14 Feb 19
Current report (foreign)
7:55am
SC 13G/A
ACST
Acasti Pharma Inc - Ordinary Shares
13 Feb 19
Acasti Pharma Inc.
12:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
8 Feb 19
Acasti Pharma Schedules Third Quarter Fiscal 2019 Conference Call
8:05am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
9 Jan 19
Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office
8:05am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
31 Dec 18
Current report (foreign)
8:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
20 Dec 18
Acasti Pharma Achieves Planned Enrollment Targets for TRILOGY Phase 3 Trials of CaPreĀ® in Patients with Severe Hypertriglyceridemia
8:01am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
14 Nov 18
Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019
8:05am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
14 Nov 18
Current report (foreign)
7:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
7 Nov 18
Acasti Pharma Schedules Second Quarter Fiscal 2019 Conference Call
8:01am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
23 Oct 18
Acasti Pharma Announces Closing of C$27.6 Million Underwritten Public Offering of Common Shares Including the Exercise of the Over-Allotment Option
9:21am
EFFECT
ACST
Acasti Pharma Inc - Ordinary Shares
18 Oct 18
Notice of effectiveness
12:15am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
15 Oct 18
Current report (foreign)
5:15pm
POS AM
ACST
Acasti Pharma Inc - Ordinary Shares
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
CORRESP
ACST
Acasti Pharma Inc - Ordinary Shares
12 Oct 18
Correspondence with SEC
12:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
11 Oct 18
Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares
7:42am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
9 Oct 18
Current report (foreign)
5:21pm